Marto Sugiono

1.8k total citations
23 papers, 1.4k citations indexed

About

Marto Sugiono is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Marto Sugiono has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Marto Sugiono's work include Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (6 papers) and Renal cell carcinoma treatment (4 papers). Marto Sugiono is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (6 papers) and Renal cell carcinoma treatment (4 papers). Marto Sugiono collaborates with scholars based in United Kingdom, Germany and Indonesia. Marto Sugiono's co-authors include David Gillatt, Steven J. Harper, David O. Bates, Jacqueline D. Shields, Mathias Winkler, Joanne M. Doughty, Danielle Peat, Jens Rassweiler, Doğu Teber and Ali Serdar Gözen and has published in prestigious journals such as Cancer Research, The Journal of Urology and British Journal of Cancer.

In The Last Decade

Marto Sugiono

23 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marto Sugiono United Kingdom 14 761 330 262 243 214 23 1.4k
W.-D. Beecken Germany 10 253 0.3× 185 0.6× 131 0.5× 175 0.7× 128 0.6× 14 768
Erik Sköldenberg Sweden 10 288 0.4× 98 0.3× 107 0.4× 96 0.4× 295 1.4× 16 771
Ron G. Rosenfeld United States 18 538 0.7× 171 0.5× 207 0.8× 108 0.4× 62 0.3× 21 1.2k
Carolyn J. Watson United Kingdom 11 702 0.9× 208 0.6× 247 0.9× 248 1.0× 14 0.1× 16 1.3k
M J Bottomley United Kingdom 9 770 1.0× 226 0.7× 251 1.0× 256 1.1× 11 0.1× 14 1.4k
Alejandro J. Garcia United States 21 602 0.8× 442 1.3× 203 0.8× 455 1.9× 196 0.9× 45 1.5k
Joshua I. Greenberg United States 12 614 0.8× 369 1.1× 287 1.1× 273 1.1× 11 0.1× 26 1.4k
L. Chauveinc France 20 165 0.2× 877 2.7× 103 0.4× 241 1.0× 61 0.3× 65 1.6k
Wolfgang Röckl Germany 8 718 0.9× 116 0.4× 172 0.7× 206 0.8× 18 0.1× 10 1.0k
Midory Thorikay Netherlands 14 1.1k 1.4× 287 0.9× 207 0.8× 397 1.6× 24 0.1× 19 1.6k

Countries citing papers authored by Marto Sugiono

Since Specialization
Citations

This map shows the geographic impact of Marto Sugiono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marto Sugiono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marto Sugiono more than expected).

Fields of papers citing papers by Marto Sugiono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marto Sugiono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marto Sugiono. The network helps show where Marto Sugiono may publish in the future.

Co-authorship network of co-authors of Marto Sugiono

This figure shows the co-authorship network connecting the top 25 collaborators of Marto Sugiono. A scholar is included among the top collaborators of Marto Sugiono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marto Sugiono. Marto Sugiono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugiono, Marto, et al.. (2025). A Case Report and Literature Review of Prostatic Tuberculosis Masquerading as Prostate Cancer: A Diagnostic Challenge in a Tuberculosis-Endemic Region. Tropical Medicine and Infectious Disease. 10(5). 145–145. 1 indexed citations
2.
Mochtar, Chaidir Arif, et al.. (2011). Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.. PubMed. 12(2). 549–53. 11 indexed citations
3.
Umbas, Rainy & Marto Sugiono. (2010). Testosterone replacement therapy in prostate cancer patients: is it safe?. PubMed. 42(3). 171–5. 2 indexed citations
4.
Perks, Claire M., et al.. (2009). PTEN‐mediated pathways and their association with treatment‐resistant prostate cancer. British Journal of Urology. 104(4). 556–561. 30 indexed citations
5.
Lim, Eugene, et al.. (2008). Prognostic Factors for Upper Tract Transitional Cell Carcinoma: A Retrospective Review of 66 Patients. Asian Journal of Surgery. 31(1). 20–24. 8 indexed citations
6.
Rennel, E S, Hui Guan, William P. J. Leenders, et al.. (2008). The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. British Journal of Cancer. 98(7). 1250–1257. 115 indexed citations
7.
Das, Kakoli, Yi Zhao, Marto Sugiono, et al.. (2007). Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 25(4). 317–321. 12 indexed citations
9.
Rassweiler, Jens, Ali Serdar Gözen, Ti̇bet Erdoğru, Marto Sugiono, & Doğu Teber. (2006). Ureteral Reimplantation for Management of Ureteral Strictures: A Retrospective Comparison of Laparoscopic and Open Techniques. European Urology. 51(2). 512–523. 122 indexed citations
10.
Sugiono, Marto, Doğu Teber, Gabriel Anghel, et al.. (2006). Assessing the Predictive Validity and Efficacy of a Multimodal Training Programme for Laparoscopic Radical Prostatectomy (LRP). European Urology. 51(5). 1332–1340. 32 indexed citations
11.
Ateş, Mutlu, Doğu Teber, Ali Serdar Gözen, et al.. (2006). A New Postoperative Predictor of Time to Urinary Continence after Laparoscopic Radical Prostatectomy: The Urine Loss Ratio. European Urology. 52(1). 178–185. 39 indexed citations
12.
Sugiono, Marto, et al.. (2005). Bicalutamide vs cyproterone acetate in preventing flare with LHRH analogue therapy for prostate cancer—a pilot study. Prostate Cancer and Prostatic Diseases. 8(1). 91–94. 22 indexed citations
13.
Winkler, Mathias, Fiqe Khan, A.A. Okeke, et al.. (2004). Case Selection for Radical Prostatectomy in the UK. European Urology. 46(4). 444–450. 1 indexed citations
14.
Winkler, Mathias, Fiqe Khan, Ivan Hoh, et al.. (2004). Time trends in case selection, stage and prostate‐specific antigen recurrence after radical prostatectomy: a multicentre audit. British Journal of Urology. 93(6). 725–729. 13 indexed citations
15.
Winkler, Mathias, Fiqe Khan, A.A. Okeke, et al.. (2004). Contemporary update of cancer control after radical prostatectomy in the UK. British Journal of Cancer. 91(11). 1853–1857. 6 indexed citations
16.
Woolard, Jeanette, Wenying Wang, Heather S. Bevan, et al.. (2004). VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant. Cancer Research. 64(21). 7822–7835. 360 indexed citations
17.
Bates, T, Marto Sugiono, E. D. James, M. STOTT, & Richard Pocock. (2003). Is the conservative management of chronic retention in men ever justified?. British Journal of Urology. 92(6). 581–583. 26 indexed citations
18.
Bates, David O., Joanne M. Doughty, Mathias Winkler, et al.. (2002). VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.. PubMed. 62(14). 4123–31. 454 indexed citations
19.
Campbell, W B, et al.. (2000). Long-term Results Following Operation for Diabetic Foot Problems: Arterial Disease Confers a Poor Prognosis. European Journal of Vascular and Endovascular Surgery. 19(2). 174–177. 26 indexed citations
20.
Sugiono, Marto, et al.. (1972). Immunoglobulin levels in malnourished children.. PubMed. 12(6). 263–70. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026